OostNL

OostNL is a development company based in Apeldoorn, Netherlands, dedicated to strengthening the regional economies of Gelderland and Overijssel. Established in 2003, it invests public funds in entrepreneurs across various sectors, including food, energy, health, logistics, and technology. In addition to financial support, OostNL provides knowledge, expertise, and a robust network to facilitate innovation and growth among businesses. The organization emphasizes a balance between financial returns and social impact, aiming to foster sustainable economic development and job creation. By focusing on sustainability, smart industry, and health-related initiatives, OostNL aims to address global social challenges while promoting entrepreneurship and internationalization in the region.

Chimwemwe de Gaay Fortman

Member of management, head of capital

72 past transactions

Pro Parents

Venture Round in 2025
Pro Parents operates an employer benefit platform for parents at work. The platform delivers training, coaching and improvement programs that include maternal and paternal health and workplace wellbeing services, enabling employers to foster a healthy, inclusive work culture.

Glampings.com

Seed Round in 2025
Glampings.com is a prominent European platform dedicated to helping individuals discover and book unique glamping experiences across the continent. The company offers a diverse range of accommodations, including luxury safari tents and adventurous tree houses, ensuring that users can find the perfect setting for their outdoor holiday. Glampings.com’s user-friendly platform allows customers to easily search, select, and reserve their ideal glamping accommodation without incurring additional reservation fees. By focusing on providing unparalleled glamping options, the company caters to a growing market of travelers seeking distinctive and comfortable outdoor experiences.

AMT Medical

Series B in 2025
AMT Medical B.V., established in 2015 and located in Ede, the Netherlands, specializes in the development of innovative medical devices for heart bypass surgery. The company's flagship product, the AMT Heart Bypass System, utilizes a minimal invasive technique known as the ELANA bypass, which was invented by neurosurgeon Prof. Dr. C.A.F. Tulleken and his research team. This advanced technology aims to enhance traditional heart bypass procedures by making them faster, safer, and less invasive, thereby improving patient outcomes and reducing complications. AMT Medical has completed the full development of its product and the production process, with all pre-clinical trials successfully concluded. The company is also preparing to initiate a clinical multi-center trial to further validate the technology's efficacy.

Grassa

Venture Round in 2025
Grassa BV specializes in the valorization of plant-based streams through bioraffinage. Based in the Netherlands, Grassa converts grass and vegetable waste into high-quality, protein-rich animal feed and other valuable products using its mobile bio-refinery technology. This process generates four main outputs: fibers, protein, phosphate, and 'wei' (sap). By transforming locally available green residual flows such as grass from meadows, agricultural waste, water plants, or nature grass, Grassa supports sustainable agriculture and helps farmers enhance their income while addressing food scarcity.

Cano-ela

Seed Round in 2025
Cano-ela is a food technology company focused on enhancing the food supply chain by eliminating refined ingredients. It specializes in processing oil-rich seeds, such as canola, to extract naturally occurring structures. The firm's innovative approach replaces conventional refined ingredients with mildly refined seed fractions, allowing clients to create natural emulsion-based food products that are environmentally sustainable and feature clean labels. Through its technology, Cano-ela aims to support the development of healthier food options while minimizing the ecological impact of food production.

Mair Therapeutics

Pre Seed Round in 2025
Mair Therapeutics is a biotechnology company focused on developing treatments for neurodegenerative disorders, with a particular emphasis on Parkinson's disease. The company's platform specializes in discovering small-molecule ion channel activators that regulate the lysosomal ion channel TMEM175, controlling lysosomal pH to degrade protein aggregates associated with these conditions. Currently, Mair Therapeutics is in the preclinical drug discovery phase.

OneThird

Series A in 2025
OneThird is a technology company focused on reducing food loss and waste through innovative IoT systems. It develops a cloud-based platform combined with handheld scanners that utilize artificial intelligence to enhance cold chain logistics. This enables retailers to scan fresh produce at distribution centers and stores, accurately predicting the remaining shelf life of items. By improving inventory management, OneThird helps retailers sell their products at the optimal time, significantly mitigating food wastage. The company's solutions are aligned with global sustainability goals, particularly in addressing the issue of food waste within the supply chain.

New Origin

Seed Round in 2025
New Origin operates as a photonic chips foundry to produce silicon nitride chips.

InsectSense

Pre Seed Round in 2025
InsectSense is a biotechnology company that develops innovative solutions inspired by insects. It uses advanced technology to mimic human, animal, and insect sensing mechanisms for measuring flavour and health properties. The company aims to create positive societal and environmental impact globally by exploring the potential of insects and enabling accurate disease diagnosis.

Alveron Pharma

Seed Round in 2024
Alveron Pharma specializes in developing treatments for hemorrhagic stroke, a critical unmet medical need. Its lead product, OKL-1111, is designed to significantly reduce hematoma expansion and offers the advantage of being a ready-to-use injection solution.

RIFT

Series A in 2024
RIFT is a startup on a mission towards a sustainable future that is powered by clean and renewable energy.

NoPalm-Ingredients

Seed Round in 2024
NoPalm Ingredients specializes in the production of sustainable microbial oils that serve as alternatives to palm and other tropical oils in the food and cosmetics industries. By utilizing fermentation technology, the company aims to eliminate the reliance on palm oil, addressing environmental concerns associated with its production. NoPalm Ingredients provides eco-friendly solutions that contribute to the reduction of greenhouse gas emissions and promote decarbonization throughout the value chain. This approach not only helps protect forests and wildlife but also supports healthier options for consumers and benefits local populations.

Hudson River Biotechnology

Venture Round in 2024
Hudson River Biotechnology is a biotechnology company focused on enhancing plants used in high-value compound production through genetic optimization.

Hexwise

Pre Seed Round in 2024
Hexwise is a company that specializes in optimizing the performance and maintenance of air-cooled heat exchangers to enhance energy efficiency across various industrial applications. The company's innovative heat exchanger optimization software is designed to reduce energy wastage and inefficiencies, particularly in sectors such as thermal power plants, gas transport networks, and chemical facilities. By providing a monitoring system that integrates with existing heat exchangers, Hexwise enables maintenance and asset managers to gain valuable insights and recommendations. This approach helps businesses improve their energy efficiency and operational effectiveness.

Time-Travelling Milkman

Seed Round in 2024
Time-Travelling Milkman produces a plant-based cream derived from sunflower seeds, serving as an ingredient for sustainable dairy alternatives.

Brilliance

Seed Round in 2023
Brilliance specializes in developing micro laser modules tailored for augmented reality displays.

Scope Biosciences

Seed Round in 2023
Scope Biosciences develops molecular diagnostics leveraging CRISPR-Cas technology. It originated as a spin-off from Wageningen University & Research. The company aims to provide actionable nucleic acid detection in healthcare and agriculture with high specificity for single-nucleotide differences and sensitivity to trace genetic material, packaged in a format that can be used outside traditional laboratory settings to support on-site decision making by clinicians and agricultural professionals.

SuperLight Photonics

Seed Round in 2023
SuperLight Photonics is a technology company that specializes in the development of advanced laser systems. Their core product is a supercontinuum generation laser, designed to serve as a versatile light source for various applications, including advanced spectroscopy, biomedical imaging, industrial inspection, and environmental sensing. This laser enables scientists, engineers, and professionals in fields like research and healthcare to study ultrafast molecular processes with high precision.

Tagworks Pharmaceuticals

Series A in 2023
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands, established in 2011 as a spin-out from Philips Healthcare. The company focuses on developing innovative in vivo chemistry to enhance the effectiveness of cancer therapies and to facilitate novel companion diagnostics. Operating from the Radboud University Medical Center in Nijmegen, Tagworks specializes in antibody-based imaging and therapy technologies. Its proprietary approach allows for the selective chemical manipulation of tagged antibodies in vivo, which improves the efficacy of established methods like radioimmuno-imaging and antibody-drug conjugates. This technology enables medical professionals to conduct imaging with significantly reduced radiation exposure for patients.

Delta Life Science

Series A in 2023
Delta Diagnostics, founded in 2018 as a spin-off from TNO – The Netherlands Organisation for Applied Scientific Research, specializes in the commercialization of advanced biosensor technology. The company focuses on developing photonic biosensors that integrate optical chips with waveguides to facilitate multiplexed biosensing. This technology enables real-time monitoring through highly sensitive refractive index sensors, allowing for label-free biosensing. Delta Diagnostics aims to provide rapid, sensitive, and cost-effective solutions that can significantly enhance research in the Life Sciences sector. By enabling accurate measurement of multiple biomarkers within minutes, the company aspires to drive new discoveries and foster the development of innovative diagnostics.

Revyve

Series A in 2023
Revyve produces premium animal-free food ingredients derived from microorganisms. Its product range includes emulsifiers, heat-set gels, and foaming agents, catering to customers with specific protein functionality needs.

PEF Technologies

Venture Round in 2023
PEF Technologies specializes in non-thermal food processing through its innovative application of nanosecond pulsed electric field technology. This method offers an alternative to traditional pasteurization, enhancing food and beverage preservation while maintaining flavor and nutritional integrity. By utilizing short-duration, high-intensity electric fields, PEF Technologies effectively extends the shelf life of products, such as juice, without compromising their bioavailability and bioaccessibility. The company's approach not only preserves the quality of nutritious components but also aims to reduce energy consumption in food processing, positioning it as a leader in sustainable food technology solutions.

OneThird

Seed Round in 2023
OneThird is a technology company focused on reducing food loss and waste through innovative IoT systems. It develops a cloud-based platform combined with handheld scanners that utilize artificial intelligence to enhance cold chain logistics. This enables retailers to scan fresh produce at distribution centers and stores, accurately predicting the remaining shelf life of items. By improving inventory management, OneThird helps retailers sell their products at the optimal time, significantly mitigating food wastage. The company's solutions are aligned with global sustainability goals, particularly in addressing the issue of food waste within the supply chain.

Pro Parents

Pre Seed Round in 2023
Pro Parents operates an employer benefit platform for parents at work. The platform delivers training, coaching and improvement programs that include maternal and paternal health and workplace wellbeing services, enabling employers to foster a healthy, inclusive work culture.

ArthroSave

Seed Round in 2023
ArthroSave specializes in joint-preserving surgical procedures aimed at younger patients suffering from knee osteoarthritis. The company has developed a medical device that addresses knee injuries and facilitates joint-saving treatments. This innovative device allows orthopedic surgeons to perform safe and painless knee replacements while maintaining the original alignment of bones and tissues. By focusing on patients under sixty-five years old with persistent knee joint damage, ArthroSave aims to improve the quality of life for individuals with knee issues, providing effective solutions tailored to their needs.

LioniX International

Venture Round in 2023
LioniX International specializes in designing and manufacturing customized Photonic Integrated Circuits (PIC), MEMS, and opto-fluidic systems. They serve original equipment manufacturers (OEMs) and system integrators, offering scalable production volumes from initial design to fully assembled modules.

Aiosyn

Seed Round in 2022
Aiosyn is a company that specializes in the development of artificial intelligence algorithms to enhance pathology diagnostics, particularly in cancer and chronic kidney diseases. By utilizing a modular software-as-a-service model, Aiosyn integrates its algorithms into existing pathology workflows, facilitating greater accuracy and efficiency in diagnostic processes. The company's platform fosters collaboration between pathologists and AI, leveraging computational pathology technology to support informed decision-making in both clinical diagnostics and drug development. Through its innovative solutions, Aiosyn aims to improve the precision of diagnoses and ultimately enhance the survival rates of patients with cancer and chronic kidney diseases.

Saia Agrobotics

Seed Round in 2022
Saia Agrobotics develops autonomous greenhouse and indoor agriculture robots designed to automate harvest and crop-handling tasks in horticulture. Its AI-powered systems enable local, healthy fresh produce production by supporting harvest and crop management, improving efficiency and consistency in controlled environments. The company's solutions aim to make indoor farming accessible and affordable, allowing farmers to control climate and shield crops from external changes, thereby achieving better yields with less land. The technology addresses food security by enabling climate-resilient, high-quality production through automation.

Secret View

Series A in 2022
Secret View operates a market research agency focused on enhancing business customer experience. It offers an affordable system for organizations to continually learn from real customer experiences via mystery shopping research, enabling retail and hospitality chains to measure and improve customer experience.

Enzyre

Series A in 2022
Enzyre develops point-of-care diagnostic technology designed to bring lab testing capabilities to patients' homes or healthcare settings. Their device focuses on blood coagulation, measuring up to twelve reactions using a small volume of blood, improving patient quality of life without increasing healthcare costs.

Fiber Unlimited

Seed Round in 2022
Fiber Unlimited specializes in products and services for indoor Plastic Optical Fiber (POF) networks, focusing on the development of telecom solutions based on optical technology. The company designs in-house products that integrate fiber-access technologies to create a comprehensive managed optical network. This network solution aims to provide a reliable, fast, and sustainable internet connection suitable for both professional and residential use. By enabling efficient communication, Fiber Unlimited addresses the growing demand for high-quality indoor network services.

Borg Energy Storage

Series A in 2022
Borg Energy Storage is focused on developing sustainable thermal energy solutions for residential buildings. The company has created a heat storage system that utilizes solar collectors to heat water during the summer months, which is then stored in a buffer tank located beneath the house or in the garden. This innovative approach allows homeowners to retain and utilize heat during the winter, enhancing energy efficiency. In addition, Borg Energy Storage provides energy management software to optimize energy use, promoting both sustainability and cost savings for users. The company's solutions are designed to improve the overall comfort and energy performance of homes.

Enliven

Venture Round in 2022
You can experience what it's like to be in someone else's shoes with Enliven's virtual reality experiences. a realistic experience that enables you to view the world from a different angle.

Pleco Therapeutics

Series A in 2022
Developer of therapies intended to treat cancer and improve the effectiveness of existing chemotherapy. The company aims to extend the life span and enhance the quality of life of patients through its novel therapies that dramatically increase the effectiveness of current cancer treatments and positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell, enabling clinicians to treat cancer and also its underlying cause.

PHIX

Debt Financing in 2022
PHIX is a packaging foundry that supplies the photonics industry with assembly and packaging services. PHIX develops optoelectronic modules on all major PIC technology platforms, including indium phosphide, silicon photonics, silicon nitride, and planar lightwave circuit. PHIX specializes in chip-to-chip hybrid integration, fiber array coupling, and the interfacing of DC and RF electrical signals.

PHIX

Venture Round in 2022
PHIX is a packaging foundry that supplies the photonics industry with assembly and packaging services. PHIX develops optoelectronic modules on all major PIC technology platforms, including indium phosphide, silicon photonics, silicon nitride, and planar lightwave circuit. PHIX specializes in chip-to-chip hybrid integration, fiber array coupling, and the interfacing of DC and RF electrical signals.

QuiX

Seed Round in 2022
QuiX BV, located in Enschede, the Netherlands, specializes in the development of integrated and reconfigurable light-based quantum processors. The company focuses on quantum information processing through its proprietary TriPleX platform, which utilizes stoichiometric Si3N4 waveguides. QuiX offers plug-and-play solutions that enable stable and efficient processing of single photons, facilitating advancements in quantum computing. By providing both integrated photonic processors and customized devices, QuiX aims to contribute significantly to the evolution of quantum technologies, paving the way for a transformative approach to information processing.

Corvus Drones

Seed Round in 2022
Corvus Drones specializes in autonomous drone applications for horticulture and crop monitoring. Their drones collect data using sensors and cameras, which is then processed via AI to provide actionable insights within an hour. This service helps reduce cultivation risk and time while promoting sustainable practices.

Clairify

Seed Round in 2022
Clairify is a company dedicated to enhancing tenant-landlord relations by focusing on the creation of productive and energy-efficient workplaces. It develops indoor climate measurement sensors that monitor air quality and comfort levels in various environments, such as schools and offices. By utilizing predictive analytics, Clairify aims to improve indoor environments, thereby increasing the well-being and productivity of building occupants. The company provides timely insights and recommendations for facility management enhancements, ultimately adding value to buildings, reducing maintenance costs, and ensuring compliance with indoor air quality regulations. Through these efforts, Clairify contributes to the development of healthy workspaces that foster better tenant experiences.

Pro Parents

Pre Seed Round in 2022
Pro Parents operates an employer benefit platform for parents at work. The platform delivers training, coaching and improvement programs that include maternal and paternal health and workplace wellbeing services, enabling employers to foster a healthy, inclusive work culture.

Aiosyn

Pre Seed Round in 2022
Aiosyn is a company that specializes in the development of artificial intelligence algorithms to enhance pathology diagnostics, particularly in cancer and chronic kidney diseases. By utilizing a modular software-as-a-service model, Aiosyn integrates its algorithms into existing pathology workflows, facilitating greater accuracy and efficiency in diagnostic processes. The company's platform fosters collaboration between pathologists and AI, leveraging computational pathology technology to support informed decision-making in both clinical diagnostics and drug development. Through its innovative solutions, Aiosyn aims to improve the precision of diagnoses and ultimately enhance the survival rates of patients with cancer and chronic kidney diseases.

Prolira BV

Venture Round in 2022
Prolira BV is a medical technology company based in Utrecht, the Netherlands, founded in 2015. It specializes in developing DeltaScan, an innovative EEG-based medical device designed for the early detection of delirium, a form of acute brain failure. The DeltaScan system comprises a single-use electrode patch known as the DeltaScan Patch and a hardware/software module called the DeltaScan Monitor, which analyzes brain activity to support clinical decision-making. Prolira is dedicated to enabling timely and effective treatment for acute encephalopathy and delirium, conditions that affect approximately 20 million patients annually in hospitals across the European Union and the United States. By providing the first EEG bedside device with a validated proprietary algorithm, Prolira aims to help clinicians optimize patient recovery, ultimately reducing long-term cognitive impairment and hospital costs.

Bilihome B.V.

Seed Round in 2022
Bilihome aims to provide an ordinary-looking romper or vest for newborns, which enables natural care and free bonding during jaundice therapy in the first week of life. The embedded smart wearables and the miniaturized system simplify the logistics and encourage care outside the hospital.

River BioMedics

Seed Round in 2022
River BioMedics is a biotech company developing 3D human cardiac tissue models for preclinical drug discovery and toxicity screening. These tissues mimic the structure and function of the human heart and provide clinically relevant readouts to assess a compound's effects on cardiac performance and safety. The company uses a stem cell-based, multidisciplinary approach to generate models that support target validation and the discovery and development of novel cardiac therapies.

ATRO Medical

Venture Round in 2021
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of anatomically shaped polymer meniscus implants, specifically the Trammpolin. This innovative prosthesis is designed to replace damaged menisci, restoring their protective function by acting as a joint spacer and shock absorber. The Trammpolin mimics the natural meniscus, facilitating adequate load distribution within the knee joint, which can provide significant relief for osteoarthritis patients suffering from severe pain. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise from a public-private collaboration initiated in 2010 that involved various universities, private companies, and support from the Dutch government. This collaborative effort has been instrumental in the design and development of the Trammpolin prototype.

Fring

Seed Round in 2021
Fring is a hiring platform designed to transform the freelance recruitment process by connecting businesses with a diverse range of freelance talent. The company offers organizations a real-time resource for accessing skilled professionals, including designers, developers, marketers, and media experts. By facilitating these connections, Fring enables companies to assemble flexible teams while providing freelancers with opportunities to engage in challenging projects. This approach aims to streamline the process of finding and hiring freelance talent, making it more efficient for both businesses and individuals seeking work.

Alveron Pharma

Seed Round in 2021
Alveron Pharma specializes in developing treatments for hemorrhagic stroke, a critical unmet medical need. Its lead product, OKL-1111, is designed to significantly reduce hematoma expansion and offers the advantage of being a ready-to-use injection solution.

Xenikos

Convertible Note in 2021
Xenikos develops innovative immunotherapy medicines using anti-T-cell antibodies. These therapies aim to reset patients' immune systems quickly and efficiently, targeting activated adult T cells to improve treatment outcomes for serious immune diseases.

ScreenPoint Medical

Series C in 2021
ScreenPoint Medical develops artificial intelligence software for breast imaging, including Transpara, to assist radiologists in reading digital breast tomosynthesis and mammography. The company focuses on deep learning and image analysis for automated interpretation of breast scans, leveraging large curated image databases and an understanding of mammography physics and clinical deployment. Its technology aims to improve early cancer detection, increase diagnostic consistency, and reduce unnecessary recalls, helping physicians screen for breast cancer earlier and enable less invasive treatment options.

Time-Travelling Milkman

Pre Seed Round in 2021
Time-Travelling Milkman produces a plant-based cream derived from sunflower seeds, serving as an ingredient for sustainable dairy alternatives.

OneThird

Seed Round in 2021
OneThird is a technology company focused on reducing food loss and waste through innovative IoT systems. It develops a cloud-based platform combined with handheld scanners that utilize artificial intelligence to enhance cold chain logistics. This enables retailers to scan fresh produce at distribution centers and stores, accurately predicting the remaining shelf life of items. By improving inventory management, OneThird helps retailers sell their products at the optimal time, significantly mitigating food wastage. The company's solutions are aligned with global sustainability goals, particularly in addressing the issue of food waste within the supply chain.

Corvus Drones

Seed Round in 2021
Corvus Drones specializes in autonomous drone applications for horticulture and crop monitoring. Their drones collect data using sensors and cameras, which is then processed via AI to provide actionable insights within an hour. This service helps reduce cultivation risk and time while promoting sustainable practices.

PESCHECK

Convertible Note in 2021
Globalization, a hybrid workforce and increasing demand from risk and compliance changed the future of employment rapidly. PESCHECK provides information and insights that make trust possible and ensure that each employee is reliably represented. By creating an actionable and robust picture of each employee. PESCHECK is the all-in-one software designed to accelerate your onboarding process with digital, fast and automated background checks. Creating a user-friendly and secure candidate experience and saves time. #automated background checks #background checks #backgroud screening #background check software #pre employment screening #in employment screening #freelancer screening #backgroud checks API #hrtech #regtech #KYE

InteRNA Technologies

Series B in 2021
InteRNA Technologies B.V. is a biotechnology company focused on developing microRNA (miRNA)-based therapeutics for cancer treatment. Founded in 2006 and headquartered in Nijmegen, the Netherlands, with a research and development center in Utrecht, the company leverages its proprietary technology to discover and validate miRNA sequences that can target multiple signaling pathways involved in cancer initiation, progression, and metastasis. By addressing previously undruggable targets, InteRNA aims to enhance the efficacy of existing cancer therapies and reduce the development of drug resistance. The company employs advanced bioinformatics and massively parallel sequencing techniques to analyze miRNA functions, paving the way for innovative treatment options in oncology.

Eurekite

Venture Round in 2021
Eurekite BV, based in Enschede, the Netherlands, specializes in the manufacture of flexible ceramic materials. Established in May 2015 as a spin-off from the University of Twente, the company focuses on the development and commercialization of its innovative technology, known as Flexiramics®. This technology emerged from the Inorganic Materials Science Group of the MESA + Institute for Nanotechnology, led by Professor Andre ten Elshof. Eurekite combines expertise in formulation chemistry, production technology, and composite development, with its disruptive materials attracting investment from prominent venture capital firms.

Pepscope

Venture Round in 2020
Pepscope is a Dutch biotechnology company that develops endogenous protein kinase activity profiling technologies, including QuantaKinome, a platform used by pharmaceutical companies and academic researchers to study kinase activity and support the discovery and development of kinase inhibitors and other therapies. The company focuses on profiling protein activity to reveal new applications for existing compounds and to guide therapy development. Its offerings span microarray- and mass spectrometry-based proteomics services and kinase profiling assays, enabling reproducible results and robust longitudinal studies. Founded in 2012 and based in Nijmegen, Pepscope aims to provide actionable proteomics insights to the pharmaceutical industry and researchers.

NutriLeads

Series B in 2020
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.

Gatt

Series B in 2020
GATT Technologies BV, established in 2011 and headquartered in Nijmegen, the Netherlands, specializes in developing innovative medical devices. The company focuses on creating synthetic surgical hemostat and sealant products designed to control severe bleeding and organ leakages during surgical procedures. Their product portfolio includes GATT-Patch, a hemostatic sealing patch for general surgery; GATT-Tape, an adhesive tape for preventing intestinal anastomotic leakage; GATT-Spray, an elastic sealant for general surgery; and GATT-Powder, a hemostatic sealing powder. These products are based on a patented synthetic technology, aiming to address challenging surgical bleeding and leakage issues.

Textmetrics

Seed Round in 2019
Textmetrics is a developer of a content quality platform that enhances the effectiveness of content delivery for organizations. By employing machine learning and artificial intelligence, the platform offers real-time suggestions to assist clients in crafting engaging content tailored to their target audience. This innovative approach enables organizations to maintain consistency in their messaging while continuously improving the conversion rates of both online and offline texts. Through augmented assisted writing based on scientifically proven algorithms, Textmetrics aims to ensure that every word counts in achieving optimal communication outcomes.

PESCHECK

Seed Round in 2019
Globalization, a hybrid workforce and increasing demand from risk and compliance changed the future of employment rapidly. PESCHECK provides information and insights that make trust possible and ensure that each employee is reliably represented. By creating an actionable and robust picture of each employee. PESCHECK is the all-in-one software designed to accelerate your onboarding process with digital, fast and automated background checks. Creating a user-friendly and secure candidate experience and saves time. #automated background checks #background checks #backgroud screening #background check software #pre employment screening #in employment screening #freelancer screening #backgroud checks API #hrtech #regtech #KYE

Prolira BV

Seed Round in 2018
Prolira BV is a medical technology company based in Utrecht, the Netherlands, founded in 2015. It specializes in developing DeltaScan, an innovative EEG-based medical device designed for the early detection of delirium, a form of acute brain failure. The DeltaScan system comprises a single-use electrode patch known as the DeltaScan Patch and a hardware/software module called the DeltaScan Monitor, which analyzes brain activity to support clinical decision-making. Prolira is dedicated to enabling timely and effective treatment for acute encephalopathy and delirium, conditions that affect approximately 20 million patients annually in hospitals across the European Union and the United States. By providing the first EEG bedside device with a validated proprietary algorithm, Prolira aims to help clinicians optimize patient recovery, ultimately reducing long-term cognitive impairment and hospital costs.

Plasmacure

Seed Round in 2018
Plasmacure, headquartered in Eindhoven, Netherlands, is a medical technology company focused on developing innovative solutions for chronic wound healing, with a particular emphasis on diabetic foot wounds. The company's core product is a patented cold plasma solution designed to kill bacteria, stimulate cell proliferation, and improve microcirculation, thereby reducing the risk of amputation and enhancing patients' quality of life.

Mimetas

Series B in 2018
MIMETAS B.V., founded in 2013 and based in Leiden, the Netherlands, specializes in the development of microfluidics-based culture plates designed for the cultivation and screening of three-dimensional organ and tissue models. The company's product line includes OrganoPlate 2-lane and 3-lane systems, which facilitate early-stage screening for drug efficacy and toxic side effects. By addressing the discrepancies between traditional in vitro and animal models and actual patient responses, MIMETAS aims to enhance the predictability of drug testing. Its OrganoPlates enable high-throughput screening of customized disease, toxicology, and transport models, thereby providing researchers and clinicians with innovative tools for compound testing and fundamental research.

SuperBuddy

Venture Round in 2017
SuperBuddy is an on-demand grocery delivery service based in the Netherlands. The company operates an online marketplace that allows users to shop for groceries from local stores. By connecting customers with personal shoppers, SuperBuddy facilitates a tailored shopping experience where users can specify their preferences. The platform ensures timely delivery, typically within a two-hour window, enabling customers to conveniently receive their selected items at their doorstep.

SoundEnergy

Venture Round in 2017
Sound Energy BV is focused on developing and commercializing innovative technologies aimed at reducing fossil energy consumption. The company specializes in Thermo Acoustic Technology, which provides a sustainable solution for climate control in buildings. By utilizing hot water for cooling, Sound Energy's heat engines and heat pumps eliminate the need for electricity or gas, allowing homeowners to manage energy consumption while achieving zero carbon dioxide emissions. With a commitment to sustainability, the company integrates environmental considerations with scientific expertise and a pragmatic business approach, ensuring that its technologies serve both ecological and economic interests.

Mellon Medical

Series B in 2017
Mellon Medical B.V., established in 2013 and based in Nijmegen, the Netherlands, specializes in the development and marketing of innovative medical suturing tools designed for surgeons. The company focuses on enhancing healthcare treatment procedures by providing advanced surgical instruments that enable single-handed stitching. This unique capability allows medical specialists to perform efficient and effective suturing of tubular and layered structures, ultimately aiming to improve patient outcomes during surgical procedures. Through its commitment to innovation in surgical technology, Mellon Medical seeks to support healthcare professionals in delivering high-quality care.

Textmetrics

Seed Round in 2017
Textmetrics is a developer of a content quality platform that enhances the effectiveness of content delivery for organizations. By employing machine learning and artificial intelligence, the platform offers real-time suggestions to assist clients in crafting engaging content tailored to their target audience. This innovative approach enables organizations to maintain consistency in their messaging while continuously improving the conversion rates of both online and offline texts. Through augmented assisted writing based on scientifically proven algorithms, Textmetrics aims to ensure that every word counts in achieving optimal communication outcomes.

ThermoSmart

Venture Round in 2017
ThermoSmart is a Dutch company that specializes in the development of a user-friendly Wi-Fi thermostat aimed at energy conservation. The thermostat operates independently from energy suppliers and boiler installers, allowing users to manage their home heating efficiently. It can be controlled via an online diary or directly from a smartphone, providing convenience and flexibility. By focusing on ease of use and energy savings, ThermoSmart offers a solution that helps consumers reduce their heating costs while maintaining comfort in their homes.

Xenikos

Series A in 2012
Xenikos develops innovative immunotherapy medicines using anti-T-cell antibodies. These therapies aim to reset patients' immune systems quickly and efficiently, targeting activated adult T cells to improve treatment outcomes for serious immune diseases.

ChargeNet

B2B e-truck charging platform
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.